Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist

Autor: Sen, S., Chen, S., Feng, B., Iglarz, M., Chakrabarti, S.
Zdroj: In Life Sciences 15 October 2012 91(13-14):658-668
Databáze: ScienceDirect